Clinical Trial Update: Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

View source ↗

Summary

A completed clinical trial investigating the molecular mechanisms underlying resistance to targeted therapy in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: COMPLETED